Welcome to the ENETS Webinar Archive

Don't worry if you missed any of the ENETS webinars - you can now view these in the ENETS webinar archive, free of charge, by clicking on the button below. ENETS has hosted numerous webinars to date in its webinar series:

2024

• ENETS-NANETS Webinar / Part 3: New insights, directions & signals - 10 July 2024
• ENETS-NANETS Webinar / Part 1: Nuclear medicine / PRRT abstracts & Part 2: Multikinase Inhibitors / Drug development - 26 June 2024
• Management of functioning syndrome in advanced NET: What can we expect? - 24 April 2024
• Theranostics in NET: Hit and Miss - 21 February 2024
• Diagnosis/treatment of rare, advanced NETS - 24 January 2024

2023

• Systemic therapy: New advances - 13 December 2023
• Local management of bone metastases in advanced NETs: What do I expect? - 27 September 2023
• SPECIAL EDITION: CHD Task Force Webinar - Synoptic reporting of echocardiography in Carcinoid Heart Disease - 27 July 2023
• How to interpret imaging results in NETs: Being aware of false positive and false negative results - 28 June 2023
• Genetic syndromes in NEN: What is new? - 19 April 2023
• Best Supportive Care: The Holistic Approach to a NET patient - 22 February 2023
• Immunotherapy: Where do we stand in NET, NEC, Pheochromocytomas and Paragangliomas (PPGL), Medullary Thyroid Carcinomas (MTC) and Merkel cell carcinomas (MCC)? - 25 January 2023

2022

• Endoscopic treatment options in localised digestive NET – When and how? - 14 December 2022
• Functioning Syndromes in NENs – From patient journey to clinical dos and don’ts: Quantifying the severity of symptoms and preventing common mistakes - 16 November 2022
• Appraisal of locoregional treatments in NET - 26 October 2022
• Update in the diagnosis and characterisation of NEN- 28 September 2022
• Selection of the most appropriate chemotherapy, type and precise modality of administration in metastatic GEP-NENs - 20 July 2022
• Role of molecular testing for individualising therapy in GEP and thoracic NENs - 29 June 2022
• Side effects/toxicity of commonly used agents: Identify risk of cumulative side effects - 25 May 2022
• Best treatment sequences in advanced NET? - 27 April 2022
• Does surgery cure localized NET? Which level of evidence? - 30 March 2022
• ABC in NEN - 26 January 2022
• Surgery of localised digestive NET - a tailored approach - 12 January 2022

2021

• "Post-OMICS" landscape and agnostic strategy - 24 November 2021
• PRRT – practical issues & "grey areas" - 27 October 2021
• Neoadjuvant and adjuvant NET therapy: Is it an option? - 29 September 2021
• New TKI results in NETs - 21 July 2021
• Advanced NET treatments: what have we learned and what do we expect? - 30 June 2021
• Neuroendocrine carcinomas (NECs): diagnostic and therapeutic - 26 May 2021
• Choosing the best treatment sequence for NET - 28 April 2021
• NEN guidelines - implementation in daily practice and unmet needs - 31 March 2021
• ABC in NEN - 27 January 2021

2020

• Highlights from ESMO 2020 - 5 November 2020
• An update on SSA including combination and maintenance therapy - 8 October 2020
• Covid-19 disease and its impact on NET therapy (incl. chemotherapy and targeted drugs) - 11 June 2020
• Covid-19 disease and its impact on NET therapy (incl. somatostatin receptor targeted therapies) - 11 June 2020